Aim: We aimed to examine the relationship between kidney size and contrast-induced nephropathy (CIN) in patients who underwent contrast-enhanced computed tomography (CT) in the emergency department.

Methods: This single-center retrospective observational study was undertaken to evaluate risk factors for CIN at Okayama Saiseikai General Hospital (Okayama, Japan) from January 2014 through to December 2016. Contrast-induced nephropathy was defined as an absolute increase in serum creatinine level of ≥0.5 mg/dL or ≥25% over the baseline value within 72 h after contrast-enhanced CT. Independent risk factors for CIN were determined by multiple logistic regression analysis. The thickness of the kidney was evaluated as a predictor of CIN using the area under the receiver operating characteristic curve. We also analyzed CIN as an outcome using the Kaplan-Meier method.

Results: The incidence of CIN was 26/262 (9.9%). In the multivariate analysis, CIN was associated with renal thickness (odds ratio = 0.65; 95% confidence interval, 0.53-0.81). No patient underwent renal replacement therapy.

Conclusion: Renal thickness could be used as a reliable, simple, and easily obtainable marker for identifying CIN in patients undergoing contrast-enhanced CT in the emergency department.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028793PMC
http://dx.doi.org/10.1002/ams2.346DOI Listing

Publication Analysis

Top Keywords

contrast-induced nephropathy
12
kidney size
8
emergency department
8
cin
8
cin patients
8
risk factors
8
factors cin
8
renal thickness
8
size early
4
early detection
4

Similar Publications

Aims: Contrast-induced nephropathy (CIN) is a condition characterized by rapidly decreasing renal funciton following by the application of contrast material. Precutaneous coronary intervention (PCI) is a life-saving treatment method that should be applied under emergent conditions. Unfortunately, the incidence of CIN after PCI is common.

View Article and Find Full Text PDF

Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease.

Prog Cardiovasc Dis

January 2025

Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA; New York Institute of Technology, Old Westbury, New York, USA. Electronic address:

Coronary artery disease (CAD) is the leading cause of mortality among patients with chronic kidney disease (CKD), presenting unique challenges in diagnosis and management. Advanced CKD patients often present with atypical symptoms, and conventional diagnostic and interventional approaches carry risks, including contrast-induced nephropathy and the potential need for renal replacement therapy. These risks have led to the phenomenon of "renalism," where necessary procedures may be deferred due to concerns over renal injury.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on elderly patients (70+) undergoing primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) at a tertiary center in Upper Egypt, highlighting a growing concern for cardiovascular disease in aging populations.
  • The research included data from 3,627 patients, finding that 15.9% were elderly, with significantly higher in-hospital mortality rates, particularly among octogenarians (23.3%) compared to younger patients (4%).
  • Elderly patients showed distinct clinical characteristics, such as higher rates of hypertension and chronic kidney disease, and were more likely to have severe complications post-procedure, emphasizing the need for tailored strategies in managing this demographic in cardiovascular care.
View Article and Find Full Text PDF

Background: Contrast-induced acute kidney injury (CI-AKI) is a frequent complication of coronary interventions associated with an increased risk of mortality and morbidity. The optimal intravenous hydration strategy to prevent CI-AKI is not well-established. The primary objective is to determine if a tailored hydration strategy reduces the risk of CI-AKI and of major adverse cardiovascular events (MACE) in patients undergoing coronary angiography compared with a non-tailored hydration strategy.

View Article and Find Full Text PDF

Purpose Of Review: This review assesses the outcomes of coronary interventions in patients with liver cirrhosis and coronary artery disease (CAD), focusing on the clinical challenges posed by cirrhosis-related hemodynamic and coagulopathic changes. It highlights essential considerations for managing these patients, who have an increased risk of adverse events during coronary procedures.

Recent Findings: Recent studies have shown that patients with liver cirrhosis undergoing PCI experience significantly higher mortality rates compared to non-cirrhotic patients, particularly in the context of STEMI and NSTEMI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!